0001104659-17-039685.txt : 20170616 0001104659-17-039685.hdr.sgml : 20170616 20170616070108 ACCESSION NUMBER: 0001104659-17-039685 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170614 FILED AS OF DATE: 20170616 DATE AS OF CHANGE: 20170616 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aralez Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001660719 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 BUSINESS PHONE: 905-876-1118 MAIL ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirsch Arthur S CENTRAL INDEX KEY: 0001290976 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37691 FILM NUMBER: 17914781 MAIL ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 STREET 2: C/O ARALEZ PHARMACEUTICALS INC. CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 4 1 a4.xml 4 X0306 4 2017-06-14 0 0001660719 Aralez Pharmaceuticals Inc. ARLZ 0001290976 Kirsch Arthur S C/O ARALEZ PHARMACEUTICALS INC., 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 ONTARIO, CANADA 1 0 0 0 Common Shares, without par value 2017-06-14 4 P 0 50000 1.1705 A 206609 D Common Shares, without par value 5000 I By Trust This transaction was executed in multiple trades at prices ranging from $1.1483 to $1.1900. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The shares are held by the Laura A. Kirsch Trust, dated 4/12/2000 (the "Trust"), of which the Reporting Person is a trustee. Pursuant to General Instruction 4(b)(iv) to Form 4, all of the Issuer's securities held by the Trust are reported herein, and the Reporting Person expressly disclaims beneficial ownership of the securities held by the Trust, except to the extent of his pecuniary interest therein. /s/ Eric L. Trachtenberg, attorney-in-fact for Arthur S. Kirsch 2017-06-16